Akrevia Therapeutics
therapeutics
Akrevia Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics. The company’s proprietary Aklusion™ platform technology allows biologics to be specifically activated in the tumor microenvironment, and with precisely tailored properties, expanding the universe of natural immune-activating proteins that can be safely delivered. Akrevia is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for patients living with cancer.
akrevia.comSkillman, Montgomery, NJ, USA, Cambridge, MA, USA
Inaccurate data? Flag it here.Open jobs at Akrevia Therapeutics